Home
Oktatas

Tantargy

Data

Official data in SubjectManager for the following academic year: 2024-2025

Course director

  • Pongrácz Judit Erzsébet

    professor,
    Faculty of Health Sciences - Institute of Health Science, Department of Public Health

Number of hours/semester

Lectures: 14 hours

Practices: 0 hours

Seminars: 14 hours

Total of: 28 hours

Subject data

  • Code of subject: OPG-GBI-T
  • 2 Credit
  • Pharmacy
  • Pharmaceutical theoretical module and practical skills module
  • spring
Prerequisites:

OPG-GAI-T finished

Course headcount limitations

min. 1 people – max. 60 people

Topic

The aim of the course is to provide basic understanding of modern, biotechnology based drug development. The course provides insight into drug development and production using the methodological and technical arsenal of biotechnology in the pharmaceutical industry.

Lectures

  • 1. Introduction. Significance of biotechnology in pharmaceutical sciences - Bóvári-Biri Judit
  • 2. Recombinant DNA technology in drug development I. - Bóvári-Biri Judit
  • 3. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 4. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 5. Recombinant proteins 1 - Garai Kitti
  • 6. Recombinant proteins 2 - Garai Kitti
  • 7. Monoclonal antibodies 1 - Bóvári-Biri Judit
  • 8. Monoclonal antibodies 2 - Bóvári-Biri Judit
  • 9. Vaccines 1 - Bóvári-Biri Judit
  • 10. Vaccines 2 - Bóvári-Biri Judit
  • 11. Cell therapy 1 - Bóvári-Biri Judit
  • 12. Cell therapy 2 - Garai Kitti
  • 13. Plant biotechnology for production therapy of small molecular drugs I. - Garai Kitti
  • 14. Plant biotechnology for production therapy of small molecular drugs II. - Garai Kitti

Practices

Seminars

  • 1. Introduction. Significance of biotechnology in pharmaceutical sciences - Bóvári-Biri Judit
  • 2. Recombinant DNA technology in drug development I. - Bóvári-Biri Judit
  • 3. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 4. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 5. Recombinant proteins 1 - Garai Kitti
  • 6. Recombinant proteins 2 - Garai Kitti
  • 7. Monoclonal antibodies 1 - Bóvári-Biri Judit
  • 8. Monoclonal antibodies 2 - Bóvári-Biri Judit
  • 9. Vaccines 1 - Garai Kitti
  • 10. Vaccines 2 - Garai Kitti
  • 11. Cell therapy 1 - Bóvári-Biri Judit
  • 12. Cell therapy 2 - Bóvári-Biri Judit
  • 13. Plant biotechnology for production therapy of small molecular drugs I. - Garai Kitti
  • 14. Plant biotechnology for production therapy of small molecular drugs II. - Garai Kitti

Reading material

Obligatory literature

Literature developed by the Department

Lecture ppt

Seminar ppt

Notes

Pharmaceutical Biotechnology departmental notes

Recommended literature

Conditions for acceptance of the semester

75% participation on lectures and tests on seminars

Mid-term exams

On the 7th week, written test

Making up for missed classes

None

Exam topics/questions

Meetstreet, Teams, Moodle

Examiners

  • Bóvári-Biri Judit
  • Garai Kitti
  • Kvell Krisztián

Instructor / tutor of practices and seminars

  • Bóvári-Biri Judit
  • Draskóczi Lilla Gréta
  • Garai Kitti
  • Papp Alexandra